Born and raised in Clayton, Missouri, Dr. Drazen majored in applied physics at Tufts University and graduated from Harvard Medical School in 1972. Dr. Drazen currently holds the positions of senior physician at the Brigham and Women’s Hospital, Distinguished Parker B. Francis Professor of Medicine at Harvard Medical School, professor of physiology at the Harvard School of Public Health and adjunct professor of medicine at the Boston University School of Medicine. He is the recipient of honorary degrees from the University of Ferrara, the University of Athens, and the University of Paris-Sud. Dr. Drazen is an elected member of the American Society for Clinical Investigation, the Association of American Physicians and the Institute of Medicine. He serves on the Institute of Medicine’s Forum on Drug Discovery, Development, and Translation.
An active researcher in the field of pulmonary medicine, Dr. Drazen defined the role of novel endogenous chemical agents in asthma. This led to four new licensed pharmaceuticals for asthma, now used in the treatment of millions of people worldwide.
He has published over 600 papers, editorials and review articles, and has edited ten books, including five editions of Goldman-Cecil Medicine and two of Asthma and COPD. In 2000, he assumed the post of editor-in-chief of the New England Journal of Medicine. During his tenure, the Journal has published major papers advancing the science of medicine, including the first descriptions of SARS, timely coverage of the Ebola epidemic, and modifications in the treatment of cancer, heart disease and lung disease, and it has been at the forefront of the worldwide effort to register all clinical trials. Since 2000, the Journal, which has over a million readers every week, has seen its ISI impact factor rise from 28 to 79, the highest impact factor for any journal publishing original research.